morphine sulfate tablet film coated extended release
INDICATIONS AND USAGE Morphine Sulfate Extended-Release Tablets are an extended-release oral formulation of morphine sulfate indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Morphine Sulfate Extended-Release Tablets are NOT intended for use as a prn analgesic. The Morphine Sulfate Extended-Release Tablets 100 and 200 mg tablet strengths are high dose, extended-release, oral morphine formulations indicated for the relief of pain in opioid-tolerant patients only. Morphine Sulfate Extended-Release Tablets are not indicated for pain in the immediate postoperative period (the first 12-24 hours following surgery) for patients not previously taking the drug, because its safety in this setting has not been established. Morphine Sulfate Extended-Release Tablets are not indicated for pain in the postoperative period if the pain is mild, or not expected to persist for an extended period of time. Morphine Sulfate Extended-Release Tablets are only indicated for postoperative use if the patient is already receiving the drug prior to surgery or if the postoperative pain is expected to be moderate to severe and persist for an extended period of time. Physicians should individualize treatment, moving from parenteral to oral analgesics as appropriate. (see American Pain Society guidelines.)
h.j. harkins company, inc.
Related Pills
Morphine Sulfate 30 MG Extended Release Oral Tablet
H.J. Harkins Company, Inc.
MS 30 MG Extended Release Tablet
H.J. Harkins Company, Inc.
Morphine Sulfate 30 MG Extended Release Oral Tablet
Rhodes Pharmaceuticals L. P.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Morphine Sulfate Extended-Release Tablets 15 mg are round, blue-colored, film-coated tablets bearing the symbol ABG on one side and 15 on the other. They are supplied as follows: NDC 42858-801-01: opaque plastic bottles containing 100 tablets Morphine Sulfate Extended-Release Tablets 30 mg are round, Lavender-colored, film-coated tablets bearing the symbol ABG on one side and 30 on the other. They are supplied as follows: NDC 42858-805-01: opaque plastic bottles containing 100 tablets Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F). Dispense in a tight, light-resistant container. Healthcare professionals can telephone Rhodes Pharmaceuticals at 1-888-827-0616 for information on this product. CAUTION DEA Order Form Required. Distributed By: Rhodes Pharmaceuticals L.P. Coventry, RI 02816 Manufactured By: Purdue Pharmaceuticals L.P. Wilson, NC 27893 Component No: 302567-0A Repacked By: H.J. Harkins Company, Inc. Nipomo, CA 93444
More pills like ROUND ABG 30